Related Experiment Video

Updated: Jun 3, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line

Xiao-Ping Chen1, Lin-Lin Qian, Hong Jiang

  • 1College of Biological and Environmental Engineering, Zhejiang University of Technology, 18 Chao-Wang Road, Hangzhou, 310014, China.

International Journal of Clinical Oncology
|April 2, 2011
PubMed
Abstract

Insights

Ginsenoside Rg3, a natural compound, may inhibit cancer metastasis by reducing CXCR4 expression. This study investigated Rg3

Area of Science:

  • Natural product chemistry
  • Cancer biology
  • Molecular oncology

Background:

  • Ginsenoside Rg3, derived from ginseng, exhibits anti-metastatic properties in cancer.
  • CXC chemokine receptor 4 (CXCR4) plays a critical role in cancer cell migration and homing to specific sites.

Purpose of the Study:

  • To investigate the effects of Ginsenoside Rg3 on CXCR4 expression in breast cancer cells.
  • To determine if Rg3 can inhibit cancer cell migration mediated by CXCR4.

Main Methods:

  • Utilized immunohistochemistry to assess CXCR4 protein levels.
  • Performed chemotaxis and wound healing assays to evaluate cell migration.
  • Studied the human breast cancer cell line MDA-MB-231.

Main Results:

  • Ginsenoside Rg3 treatment, at non-cytotoxic doses, reduced CXCR4 expression.
  • Rg3 significantly decreased the migration of cancer cells in response to CXCL12.
  • Wound healing assays showed reduced cell mobility upon Rg3 treatment.

Conclusions:

  • Ginsenoside Rg3 acts as a novel inhibitor of CXCR4.
  • This natural product demonstrates potential for targeting cancer metastasis pathways.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: